Form 4 Tracker
Kymera Therapeutics, Inc.
KYMR

54 insider filings · Latest: Oct 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 2, 2026Mar 2 10:07 PMChadwick Jeremy G
Proposed Sale
6,206$90.10$559.2K—

View →

Mar 2, 2026Mar 2 10:06 PMJacobs Bruce N.
Proposed Sale
12,576$90.10$1.1M—

View →

Feb 25, 2026Feb 25 10:24 PMNello MainolfiDirector, Chief Executive Officer
Sale
30,000$90.26$2.7M666,195(D)

View →

Feb 25, 2026Feb 25 9:03 PMMainolfi Nello
Proposed Sale
30,000$91.40$2.7M—

View →

Feb 20, 2026Feb 20 10:30 PMPamela EspositoDirector
Sale
2,500$87.31$218.3K0(D)

View →

Feb 20, 2026Feb 20 9:28 PMPAMELA ESPOSITO
Proposed Sale
2,500$86.50$216.3K—

View →

Jan 20, 2026Jan 20 11:30 PMPamela EspositoDirector
Sale
5,500$67.91$373.5K0(D)

View →

Jan 20, 2026Jan 20 9:29 PMPAMELA ESPOSITO
Proposed Sale
5,500$69.54$382.5K—

View →

Dec 31, 2025Dec 31 10:23 PMNello MainolfiDirector, Chief Executive Officer
Sale
30,000$78.06$2.3M663,077(D)

View →

Dec 31, 2025Dec 31 9:06 PMMainolfi Nello
Proposed Sale
30,000$77.69$2.3M—

View →

Dec 17, 2025Dec 17 9:23 PMPAMELA ESPOSITO
Proposed Sale
27,563$84.19$2.3M—

View →

Dec 12, 2025Dec 12 10:20 PMAtlas Venture Opportunity Fund I, L.P.
Proposed Sale
108$89.68$9.7K—

View →

Dec 12, 2025Dec 12 10:08 PMAtlas Venture Fund X, L.P.
Proposed Sale
570$89.68$51.1K—

View →

Dec 11, 2025Dec 11 10:13 PMAtlas Venture Opportunity Fund I, L.P.
Proposed Sale
976$87.81$85.7K—

View →

Dec 11, 2025Dec 11 10:01 PMAtlas Venture Fund X, L.P.
Proposed Sale
5,125$87.81$450.0K—

View →

Dec 10, 2025Dec 10 11:39 PMAtlas Venture Opportunity Fund I, L.P.
Proposed Sale
36,769$89.89$3.3M—

View →

Dec 10, 2025Dec 10 11:31 PMAtlas Venture Fund X, L.P.
Proposed Sale
193,040$89.89$17.4M—

View →

Dec 8, 2025Dec 8 11:05 PMMainolfi Nello
Proposed Sale
100,000$89.17$8.9M—

View →

Dec 8, 2025Dec 8 11:03 PMJared Gollob
Proposed Sale
49,307$66.62$3.3M—

View →

Dec 8, 2025Dec 8 11:03 PMJEFFREY ALBERS
Proposed Sale
5,000$66.62$333.1K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 4 11:00 PMJared GollobChief Medical Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMBruce N. JacobsChief Financial Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMNello MainolfiDirector, Chief Executive Officer
Grant/Award
215,000$90.10215,000(D)

View →

Feb 25, 2026Feb 25 10:24 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08245,559(D)

View →

Feb 20, 2026Feb 20 10:30 PMPamela EspositoDirector
Option Exercise
2,500$49.102,500(D)

View →

Jan 20, 2026Jan 20 11:30 PMPamela EspositoDirector
Option Exercise
5,500$49.105,000(D)

View →

Dec 31, 2025Dec 31 10:23 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08275,559(D)

View →

← Previous

Page 3 of 3